Bone Marrow Transplant Complications
20
6
10
4
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
10.0%
2 terminated out of 20 trials
66.7%
-19.8% vs benchmark
5%
1 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (20)
Diagnostic Refinement and Educational Approaches in Managing Bone Marrow Transplantation
A Novel Digital Application (SHIFT) to Improve Outcomes for Hematopoietic Stem Cell Transplant Survivors
Multidisciplinary Intervention for Adults With Chronic Graft-versus-host Disease
Using Ultrasound Elastography to Predict Development of Hepatic Sinusoidal Obstruction Syndrome
Mobile CARE-App to Promote Coping for Caregivers of Patients Receiving Stem Cell Transplant
BMT-CARE: Psychosocial Intervention for Transplant Caregivers
Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors
Virtual Reality Intervention for Patients Undergoing BMT
Vaginal Microbiome and the Development of Vulvovaginal Graft Versus Host Disease
Ultrasound Elastography to Predict Development of SOS
Genetics in the Progression of Nephropathies
High-Dose Post-Transplant Cyclophosphamide, Bortezomib, and Sitagliptin for the Prevention of GVHD
Nutrition and Metabolic Prehabilitation in HSCT Patients UK and ROI. BSBMT Multi-centre Survey.
Observational Study to Evaluate Hematopoietic Progenitor Cell Mobilization in Patients With Newly Diagnosed Multiple Myeloma
Reiki Effects on Bone Marrow Transplant Patients
Assessment of Efficacy of LightWalker (Nd:Yag, Er:Yag) Laser Therapy on Incidence, Severity and Duration of Oral Mucositis in Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT). Prospective Randomized Open-label Study
5-day Defibrotide Treatment for Hepatic SOS/VOD
Feasibility and Efficacy of Modified Donor Lymphocytes Infusion (CD45RA Negative Selected) After Haploidentical Transplantation With Post-transplantation Cyclophosphamide in Patients With Hematological Malignancies (ONC-2016-002).
Validating Ultrasound Biomarkers for Hepatic Sinusoidal Obstruction Syndrome in Pediatric Hematopoietic Cell Transplant Patients
Post Transplant Cyclophosphamide in Matched Unrelated Donor Stem Cell Transplantation for Hematological Malignancies